Diasorin | DIA - Sales Revenues

Stock Price
74.07
Daily Change
-0.51 -0.68%
Monthly
3.19%
Yearly
-26.19%
Q1 Forecast
70.01

Diasorin reported EUR280M in Sales Revenues for its fiscal quarter ending in September of 2025.





Sales Change Date
Amplifon EUR 563.3M 29.55M Sep/2025
Avanos Medical USD 177.8M 2.8M Sep/2025
Brookdale Senior Living USD 813.16M 34.92M Sep/2025
Cencora USD 85.9B 5.2B Sep/2025
Diasorin EUR 280M 26M Sep/2025
Encompass Health USD 1.54B 60M Dec/2025
Enovis USD 548.9M 15.64M Sep/2025
GE HealthCare Technologies USD 5.14B 137M Sep/2025
OPKO Health USD 151.67M 5.14M Sep/2025
Zimmer Biomet Holdings USD 2B 80M Sep/2025